Stay updated on Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The Study Details page for NCT03412773 appears the same in both screenshots, with no changes to the main study information.
    Difference
    0.2%
    Check dated 2025-11-03T13:22:48.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added detailed trial results and substudy information for the tislelizumab vs sorafenib study (RATIONALE-301), including endpoints, locations, and Japanese safety run-in; removed reference to the 2024-01-10 results submission page in favor of the updated results-centric content.
    Difference
    100%
    Check dated 2025-10-20T07:22:25.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Update includes a government operations notice and new version tag v3.2.0, replacing v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T02:01:32.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-28T23:25:15.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page revision is updated from v3.0.1 to v3.0.2. The 'Back to Top' navigation element has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T09:42:24.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T07:19:26.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.